Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Could a smart patch help older diabetics ditch the finger pricks?

NCT ID NCT07007676

Disease control Sponsor: Shanghai 6th People's Hospital Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Sep 09, 2026 · Updated 2 times

Summary

This study is testing whether a continuous glucose monitor (CGM) can help older adults with type 2 diabetes who do not use insulin achieve better blood sugar control. Participants will either wear a CGM every two months or use standard finger-stick monitoring for six months. The main goal is to see if CGM leads to a greater drop in HbA1c levels.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
continuous glucose monitoring device
What this could lead to
If successful, this could show that continuous glucose monitors help older adults with type 2 diabetes manage their blood sugar better without needing insulin.
What could go wrong
This is a small, early-stage trial with only 148 participants, and the benefit may not be large enough to change standard care. The device may also be less accurate or harder to use in older adults.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 148 people

The number the study aims to enrol. It can still change while the study runs.

Started

Jul 2025

Expected to finish

Jun 2027

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

60 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Age ≥ 60 years at the time of screening; * Diagnosed with type 2 diabetes mellitus; * Treated with two or more oral antidiabetic drugs with a stable medication regimen (medication classes) during the 3 months prior to entry; * Suboptimal glycemic control, defined as HbA1c ≥ 7.5% and ≤ 10% at screening or within 30 days prior to screening visit; * Has a smart phone compatible with CGM and BGM systems; * Willing and able to provide written informed consent; * At least 240 hours (10 out of 14 days) of sensor glucose data from the blinded CGM pre-randomization phase. Exclusion Criteria: * Use of insulin or Glucagon-Like Peptide-1 （GLP-1） receptor agonists within 3 months prior to screening; * Use of any CGM device within 3 months prior to screening; * Participants were unable to tolerate tape adhesive around sensor placement area, or with medically documented allergy towards the adhesive (glue) of plasters, or with serious skin diseases (e.g. psoriasis vulgaris, bacterial skin diseases) around sensor placement area; * Considered unsuitable for participation by the investigators, including but not limited to individuals with dementia, psychiatric disorders, extreme visual or hearing impairment that would impair ability to use real-time CGM assessed; * Planned surgery or other procedures within the next 6 months that may interfere with scheduled follow-up visits; * Current or anticipated acute uses of glucocorticoids (oral, injectable, or IV), that will affect glycemic control; * Estimated glomerular filtration rate (eGFR) \< 30 ml/min/1.73m2; * Participation in any other clinical trial within 3 month prior to screening, or concurrently enrolled, or planning to participate in another trial during the study period.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Diabetes mellitus type 2 are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

type 2 diabetes mellitus

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Diabetes mellitus type 2

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    21 sites. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Guantian Community Health Service Station

    RECRUITING

    Shenzhen, Guangdong, 518108, China

  • Huiyu Mingdu Community Health Service Station

    RECRUITING

    Shenzhen, Guangdong, 518108, China

  • Langxin Community Health Service Station

    RECRUITING

    Shenzhen, Guangdong, 518108, China

  • Luozu Community Health Service Center

    RECRUITING

    Shenzhen, Guangdong, 518108, China

  • Shenzhen Buxin Community Health Service Center

    RECRUITING

    Shenzhen, Guangdong, China

  • Shenzhen Dalang Community Health Service Center

    RECRUITING

    Shenzhen, Guangdong, China

  • Shenzhen Fifth Avenue Health Service Station

    RECRUITING

    Shenzhen, Guangdong, 518000, China

  • Shenzhen Haifu Health Service Station

    RECRUITING

    Shenzhen, Guangdong, 518000, China

  • Shenzhen Haihua Community Health Service Center

    RECRUITING

    Shenzhen, Guangdong, China

  • Shenzhen Haile Community Health Service Station

    RECRUITING

    Shenzhen, Guangdong, China

  • Shenzhen Haile Huafu Health Service Station

    RECRUITING

    Shenzhen, Guangdong, 518000, China

  • Shenzhen Haiyu Health Service Station

    RECRUITING

    Shenzhen, Guangdong, 518000, China

  • Shenzhen Jiaan Health Service Station

    RECRUITING

    Shenzhen, Guangdong, 518000, China

  • Shenzhen Jiangangshan Health Service Center

    RECRUITING

    Shenzhen, Guandong, 518000, China

  • Shenzhen Jiari Mingju Health Service Station

    RECRUITING

    Shenzhen, Guangdong, 518000, China

  • Shenzhen Pingzhou Community Health Service Center

    RECRUITING

    Shenzhen, Guangdong, China

  • Shenzhen Xinan Lake Health Service Station

    RECRUITING

    Shenzhen, Guangdong, 518000, China

  • Shenzhen Xingdong Health Service Station

    RECRUITING

    Shenzhen, Guangdong, 518000, China

  • Shenzhen Zhongliang Chuangxin Health Service Station

    RECRUITING

    Shenzhen, Guangdong, 518000, China

  • Shuitian Health Service Center

    RECRUITING

    Shenzhen, Guangdong, 518108, China

  • Tianbao Community Health Service Center

    RECRUITING

    Shenzhen, Guangdong, 518108, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.